Trade deals are driving the recovery for U.S. stocks with the S&P 500 erasing all of its losses post Liberation Day.

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Investors eye more trade deals, updates from President Trump’s trip to the Middle East and fresh consumer inflation data ...

Markets cheer tariff reprieve, Republican budget proposal includes funding cuts to Medicaid, Tesla worth $1 trillion, more ...

ACM Research (NASDAQ: ACMR) is a U.S.-based company, but it sells its products extensively in China. The stock surged nearly ...

Less than two weeks after blaming former President Joe Biden for stocks’ weak performance, President Donald Trump is making it sound like it’s his market again. As the S&P 500 [turned positive for the ...

Palantir's stock is seeing a boost from reports that the U.S. and Saudi Arabian governments have reached a new deal that ...

US President Donald Trump has signed an executive order aimed at reducing drug costs for Americans, by up to 80% immediately.

Indian pharma stocks fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...

Bloomberg News Now is a comprehensive audio report of today's top stories. Hear the latest news, updated throughout the day, covering global business stories in just a few minutes.

The stock markets are soaring, but will President Donald Trump also enjoy a political payoff in public opinion polling in the wake of a tariff truce with China?